| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |